← k3vl4r
Log inGet started →

SPRY (ARS Pharmaceuticals Inc) Price Forecast

AI-generated price forecast for ARS Pharmaceuticals Inc (SPRY) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of November 2026: K3vl4r's calibrated AI forecast currently reads SPRY as 1/1 bearish across its horizons (0 of 1 timeframes pointing up), with a last price of 3.14. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

3.14

AI outlook

1/1 bearish

Timeframes up

0 / 1

Share𝕏PostTelegram

SPRY forecast by horizon

HorizonDirectionCalibrated move (end of horizon)
1-hour——
4-hour——
Daily~4 weeks out▼ Down-61.85%
WeeklyNot enough track record yet—

Calibrated: each horizon's forecast is weighted by how often the model has called SPRY's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.

Latest SPRY news

From the market-news feed the forecasts are read against.

  • ARS Pharmaceuticals: Neffy Is Gaining Traction, But Revenue Growth Needs To Catch Up · SeekingAlpha · Nov 18
  • ARS Pharmaceuticals Inc (SPRY) Q3 2026 Earnings Call Highlights: neffy Market Share Tops 5% as ... · Yahoo · Nov 6
  • ARS Pharmaceuticals Analysts Cut Their Forecasts After Downbeat Q3 Results · Benzinga · Nov 6
  • Cantor Fitzgerald Maintains Overweight on ARS Pharmaceuticals, Lowers Price Target to $20 · Benzinga · Nov 6
  • ARS Pharmaceuticals, Inc. (SPRY) Q3 2026 Earnings Call Transcript · SeekingAlpha · Nov 6

🔒

See the full SPRY forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

SPRY forecast — frequently asked

Will SPRY go up?

K3vl4r's calibrated AI forecast currently reads SPRY as 1/1 bearish — 0 of 1 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the SPRY price prediction for 2026?

K3vl4r's model projects SPRY toward $1.20 over the next ~4 weeks, a -61.9% move from $3.14. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

CRVSLQDACABAEVGNGMEDGOSSQTTBSLDBTNGXENLVOGNOSUREYPTRCUS

Will SPRY reach…?

Will SPRY reach $5.00?Will SPRY reach $10.00?Will SPRY reach $20.00?Will SPRY reach $25.00?

Or see the full SPRY price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare SPRY

SPRY vs CRVSSPRY vs LQDASPRY vs CABASPRY vs EVGNSPRY vs GMEDSPRY vs GOSS

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rResearch libraryTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.